Astec LifeSciences announced that ICRA has reaffirmed / assigned the following credit ratings:
(a) Assigned / Re-affirmed ICRA AA- (Stable) rating for long-term Bank facilities of Rs.556 crore. Outlook on the long-term rating is revised from Positive to Stable.
(b) Assigned / Re-affirmed ICRA A1+ rating for short-term Bank facilities of Rs.425 crore;
(c) Re-affirmed "ICRA A1+" rating to the existing Rs.300 crore Commercial Paper programme of the Company.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
